CONNEXT
PrivateLast Round
Series C
Mar 16, 2026
Total Funding Raised
$10.02M
Momentum Score
50 /100
Company Overview
CONNEXT is a biotechnology company that develops biological therapeutics, including a recombinant TLR5 agonist and a recombinant collagenase for fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CONNEXT Comps
Public and private peers based on sector, stage, and business model.
CONNEXT Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 16, 2026 | ||||
| VC Round | Apr 16, 2021 |
CONNEXT Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Investment | VC Round |
| Murex Partners | Series C |
| Premier Partners | Series C |
| ES Investor | Series C |
| LSK Investment | VC Round |
| SU Investment Capital | Series C |
CONNEXT Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CONNEXT's valuation, stock price, and market status.
